Prospects for reprogramming the immune system in multiple sclerosis

Prospects for reprogramming the immune system in multiple sclerosis

ग्रंथसूची विवरण
मुख्य लेखक:	Waldmann, H
स्वरूप:	Conference item
प्रकाशित:	2007

समान संसाधन

Reprogramming the immune system.
द्वारा: Waldmann, H
प्रकाशित: (2008)

Reprogramming the immune system.
द्वारा: Waldmann, H
प्रकाशित: (2002)

REPROGRAMMING THE IMMUNE-SYSTEM
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (1993)

Reprogramming the immune system using antibodies.
द्वारा: Graca, L, और अन्य
प्रकाशित: (2006)

Reprogramming the immune system for tolerance with monoclonal antibodies.
द्वारा: Cobbold, S, और अन्य
प्रकाशित: (1990)

Reprogramming the immune system towards regulation
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (2010)

Reprogramming the immune system: co-receptor blockade as a paradigm for harnessing tolerance mechanisms.
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (2008)

Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
द्वारा: Cobbold, S, और अन्य
प्रकाशित: (1992)

Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model
द्वारा: Sofia Pereira das Neves, और अन्य
प्रकाशित: (2023-10-01)

Reprogramming the immune system: a possible therapeutic approach to established autoimmune disease.
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (1993)

Effect of puberty on the immune system: Relevance to multiple sclerosis
द्वारा: Carmen C. Ucciferri, और अन्य
प्रकाशित: (2022-12-01)

Cortical injury in multiple sclerosis; the role of the immune system
द्वारा: Walker Caroline A, और अन्य
प्रकाशित: (2011-12-01)

Immune-mediated genesis of multiple sclerosis
द्वारा: Salvatore Cavallo, MD, Specialist in Medical Genetics
प्रकाशित: (2020-01-01)

Similarities in the Metabolic Reprogramming of Immune System and Endothelium
द्वारा: Chu-Yik Tang, और अन्य
प्रकाशित: (2017-07-01)

THE INVERSION OF HOMEOSTATIC PROPERTIES OF THE IMMUNE SYSTEM IN PATIENTS WITH MULTIPLE SCLEROSIS
द्वारा: I. I. Andreevа, और अन्य
प्रकाशित: (2016-06-01)

CAMPATH-IH in multiple sclerosis.
द्वारा: Moreau, T, और अन्य
प्रकाशित: (1996)

Prospects of siponimod in secondary progressive multiple sclerosis
द्वारा: Marisa McGinley, और अन्य
प्रकाशित: (2018-07-01)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
द्वारा: Shaojie Wu, और अन्य
प्रकाशित: (2021-01-01)

The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
द्वारा: Alessandro Maglione, और अन्य
प्रकाशित: (2019-10-01)

Role of innate immune cells in multiple sclerosis
द्वारा: Carolina Prado, और अन्य
प्रकाशित: (2025-02-01)

Pulsed immune reconstitution therapy in multiple sclerosis
द्वारा: Per Soelberg Sorensen, और अन्य
प्रकाशित: (2019-03-01)

Prospects for the use of curcumin as an additional treatment for multiple sclerosis
द्वारा: V. S. Rogovskii, और अन्य
प्रकाशित: (2023-08-01)

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
द्वारा: Moreau, T, और अन्य
प्रकाशित: (1996)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
द्वारा: I. P. Ivanova, और अन्य
प्रकाशित: (2021-10-01)

EBV-specific T-cell immunity: relevance for multiple sclerosis
द्वारा: Malina Behrens, और अन्य
प्रकाशित: (2024-12-01)

Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
द्वारा: Norma Y. Hernández-Pedro, और अन्य
प्रकाशित: (2013-01-01)

Acetate correlates with disability and immune response in multiple sclerosis
द्वारा: Silvia Pérez-Pérez, और अन्य
प्रकाशित: (2020-11-01)

Neuro-immune crosstalk in depressive symptoms of multiple sclerosis
द्वारा: Chao Wang, और अन्य
प्रकाशित: (2023-02-01)

CD8+ T cells as immune regulators of multiple sclerosis
द्वारा: Sushmita eSinha, और अन्य
प्रकाशित: (2015-12-01)

Cerebrospinal fluid cells immune landscape in multiple sclerosis
द्वारा: Zijian Li, और अन्य
प्रकाशित: (2021-03-01)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
द्वारा: Kyle K. Payne, और अन्य
प्रकाशित: (2012-01-01)

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
द्वारा: Cox, A, और अन्य
प्रकाशित: (2005)

Understanding and Modulating Immunity With Cell Reprogramming
द्वारा: Cristiana F. Pires, और अन्य
प्रकाशित: (2019-12-01)

The cancer metabolic reprogramming and immune response
द्वारा: Longzheng Xia, और अन्य
प्रकाशित: (2021-02-01)

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens
द्वारा: Giulia Escobar, और अन्य
प्रकाशित: (2018-07-01)

Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
द्वारा: I. V. Smagina, और अन्य
प्रकाशित: (2010-08-01)

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects
द्वारा: Jiwon Oh, और अन्य
प्रकाशित: (2014-09-01)

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.
द्वारा: Jarius, S, और अन्य
प्रकाशित: (2008)

Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update
द्वारा: Wu S, और अन्य
प्रकाशित: (2023-09-01)

Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma
द्वारा: Songlei Zhou, और अन्य
प्रकाशित: (2023-01-01)